AMN HealthcareAMN
About: AMN Healthcare Services Inc provides healthcare workforce solutions and staffing services in the United States. Its comprehensive suite of talent solutions provides management, staffing, recruitment, language services, technology, predictive and market analytics, and related services to build and manage all or parts of the clients' healthcare workforce needs. Its reportable segments are; nurse and allied solutions, physician and leadership solutions, and technology and workforce solutions. A majority of its revenue is generated from the nurse and allied solutions segment which includes the company's travel nurse staffing, labor disruption staffing, local staffing, international nurse permanent placement, and allied staffing (including revenue cycle solutions) businesses.
Employees: 2,968
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
2% less repeat investments, than reductions
Existing positions increased: 95 | Existing positions reduced: 97
5% less call options, than puts
Call options by funds: $4.02M | Put options by funds: $4.24M
11.39% less ownership
Funds ownership: 115.38% [Q3] → 103.99% (-11.39%) [Q4]
15% less funds holding
Funds holding: 321 [Q3] → 273 (-48) [Q4]
47% less first-time investments, than exits
New positions opened: 50 | Existing positions closed: 94
49% less capital invested
Capital invested by funds: $1.86B [Q3] → $953M (-$905M) [Q4]
Research analyst outlook
4 Wall Street Analysts provided 1 year price targets over the past 3 months
4 analyst ratings
BMO Capital Jeffrey Silber 40% 1-year accuracy 17 / 43 met price target | 38%upside $33 | Outperform Maintained | 24 Feb 2025 |
Citizens Capital Markets Constantine Davides 30% 1-year accuracy 10 / 33 met price target | 38%upside $33 | Market Outperform Maintained | 24 Feb 2025 |
Truist Securities Tobey Sommer 28% 1-year accuracy 13 / 47 met price target | 67%upside $40 | Buy Maintained | 21 Feb 2025 |
JMP Securities Constantine Davides 30% 1-year accuracy 10 / 33 met price target | 42%upside $34 | Market Outperform Reiterated | 6 Feb 2025 |
Financial journalist opinion
Based on 4 articles about AMN published over the past 30 days
